Current Report Filing (8-k)
18 Décembre 2020 - 10:13PM
Edgar (US Regulatory)
0000051143
false
--12-31
Capital stock, par value $.20 per share
IBM
CHX
0000051143
2020-12-15
2020-12-15
0000051143
us-gaap:CommonStockMember
exch:XCHI
2020-12-15
2020-12-15
0000051143
us-gaap:CommonStockMember
exch:XNYS
2020-12-15
2020-12-15
0000051143
ibm:Notes0.500PercentDue2021Member
exch:XNYS
2020-12-15
2020-12-15
0000051143
ibm:Notes2.625PercentDue2022Member
exch:XNYS
2020-12-15
2020-12-15
0000051143
ibm:Notes1.25PercentDue2023Member
exch:XNYS
2020-12-15
2020-12-15
0000051143
ibm:Notes0.375PercentDue2023Member
exch:XNYS
2020-12-15
2020-12-15
0000051143
ibm:Notes1.125PercentDue2024Member
exch:XNYS
2020-12-15
2020-12-15
0000051143
ibm:Notes2.875PercentDue2025Member
exch:XNYS
2020-12-15
2020-12-15
0000051143
ibm:Notes0.950PercentDue2025Member
exch:XNYS
2020-12-15
2020-12-15
0000051143
ibm:Notes0.875PercentDue2025Member
exch:XNYS
2020-12-15
2020-12-15
0000051143
ibm:Notes0.300PercentDue2026Member
exch:XNYS
2020-12-15
2020-12-15
0000051143
ibm:Notes1.250PercentDue2027Member
exch:XNYS
2020-12-15
2020-12-15
0000051143
ibm:Notes0.300PercentDue2028Member
exch:XNYS
2020-12-15
2020-12-15
0000051143
ibm:Notes1.750PercentDue2028Member
exch:XNYS
2020-12-15
2020-12-15
0000051143
ibm:Notes1.500PercentDue2029Member
exch:XNYS
2020-12-15
2020-12-15
0000051143
ibm:Notes1.750PercentDue2031Member
exch:XNYS
2020-12-15
2020-12-15
0000051143
exch:XNYS
ibm:Notes0.650PercentDue2032Member
2020-12-15
2020-12-15
0000051143
exch:XNYS
ibm:Notes1.200PercentDie2040Member
2020-12-15
2020-12-15
0000051143
ibm:Debentures7.00PercentDue2025Member
exch:XNYS
2020-12-15
2020-12-15
0000051143
ibm:Debentures6.22PercentDue2027Member
exch:XNYS
2020-12-15
2020-12-15
0000051143
ibm:Debentures6.50PercentDue2028Member
exch:XNYS
2020-12-15
2020-12-15
0000051143
ibm:Debentures7.00PercentDue2045Member
exch:XNYS
2020-12-15
2020-12-15
0000051143
ibm:Debentures7.125PercentDue2096Member
exch:XNYS
2020-12-15
2020-12-15
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
|
Title of each class
|
Capital stock, par value $.20 per share
|
|
Trading
symbol
|
IBM
|
|
|
Common Stock
|
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
8-K
CURRENT
REPORT PURSUANT TO SECTION 13 OR 15 (d)
OF
THE SECURITIES EXCHANGE ACT OF 1934
Date
of Report: December 15, 2020
(Date of earliest
event reported)
INTERNATIONAL BUSINESS MACHINES CORPORATION
(Exact name of registrant
as specified in its charter)
|
New York
|
|
1-2360
|
|
13-0871985
|
|
(State of Incorporation)
|
|
(Commission File Number)
|
|
(IRS employer Identification No.)
|
|
One New Orchard Road
|
|
|
Armonk,
New York
|
10504
|
|
(Address of principal executive offices)
|
(Zip Code)
|
914-499-1900
(Registrant’s
telephone number)
Check the appropriate
box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:
|
¨
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
|
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
|
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
|
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Securities
registered pursuant to Section 12(b) of the Act:
|
Title
of each class
|
|
Trading
symbol(s)
|
|
Name
of each exchange
on which registered
|
|
Capital stock, par value $.20 per share
|
|
IBM
|
|
New York Stock Exchange
|
|
|
|
|
|
NYSE Chicago
|
|
0.500% Notes due 2021
|
|
IBM 21B
|
|
New York Stock Exchange
|
|
2.625% Notes due 2022
|
|
IBM 22A
|
|
New York Stock Exchange
|
|
1.250% Notes due 2023
|
|
IBM 23A
|
|
New York Stock Exchange
|
|
0.375% Notes due 2023
|
|
IBM 23B
|
|
New York Stock Exchange
|
|
1.125% Notes due 2024
|
|
IBM 24A
|
|
New York Stock Exchange
|
|
2.875% Notes due 2025
|
|
IBM 25A
|
|
New York Stock Exchange
|
|
0.950% Notes due 2025
|
|
IBM 25B
|
|
New York Stock Exchange
|
|
0.875% Notes due 2025
|
|
IBM 25C
|
|
New York Stock Exchange
|
|
0.300% Notes due 2026
|
|
IBM 26B
|
|
New York Stock Exchange
|
|
1.250% Notes due 2027
|
|
IBM 27B
|
|
New York Stock Exchange
|
|
0.300% Notes due 2028
|
|
IBM 28B
|
|
New York Stock Exchange
|
|
1.750% Notes due 2028
|
|
IBM 28A
|
|
New York Stock Exchange
|
|
1.500% Notes due 2029
|
|
IBM 29
|
|
New York Stock Exchange
|
|
1.750% Notes due 2031
|
|
IBM 31
|
|
New York Stock Exchange
|
|
0.650% Notes due 2032
|
|
IBM 32A
|
|
New York Stock Exchange
|
|
1.200% Notes due 2040
|
|
IBM 40
|
|
New York Stock Exchange
|
|
7.00% Debentures due 2025
|
|
IBM 25
|
|
New York Stock Exchange
|
|
6.22% Debentures due 2027
|
|
IBM 27
|
|
New York Stock Exchange
|
|
6.50% Debentures due 2028
|
|
IBM 28
|
|
New York Stock Exchange
|
|
7.00% Debentures due 2045
|
|
IBM 45
|
|
New York Stock Exchange
|
|
7.125% Debentures due 2096
|
|
IBM 96
|
|
New York Stock Exchange
|
Indicate by check mark
whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2
of this chapter).
Emerging growth company
¨
If an emerging growth
company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any
new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Item 5.02(b) Departure of
Named Executive Officer and Item 5.02(e) Compensatory Arrangement for Named Executive Officer.
On December 15, 2020, Dr.
John E. Kelly III, Executive Vice President, age 66, decided to retire from the Company on December 31, 2020, after a more than
40-year career with IBM.
After Dr. Kelly’s retirement from the company, he may
be asked, from time to time, to provide services to the company as an independent contractor. The fee for such services would be
$7,800 per day for each day he provides four or more hours of services and $3,900 per day for each day that he provides less than
four hours.
The consulting arrangement is set forth in the Letter attached
as Exhibit 99.1.
Item 5.03(a) Amendment to Bylaws.
On
December 15, 2020, the IBM Board of Directors adopted amendments to IBM’s By-laws, effective January 1, 2021, to (i)
amend Article III, Section 2, to decrease the number of
directors from fourteen to thirteen as a result of the previously disclosed retirement of Virginia M. Rometty, (ii)
add Article III, Section 11 to permit stockholders to remove a director, with or without cause, at any time, by a vote of the
stockholders and (iii) make a few minor changes throughout the By-Laws to clarify the Vice Chairman officer
position.
The foregoing description of the amendments to the By-laws is
qualified in its entirety by the text of the By-laws, a copy of which is attached hereto as Exhibit 3.2 and incorporated herein
by reference.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
The following exhibits are being filed as part of this report:
IBM’s web site (www.ibm.com) contains a significant amount
of information about IBM, including financial and other information for investors (www.ibm.com/investor/). IBM encourages investors
to visit its various web sites from time to time, as information is updated and new information is posted.
SIGNATURE
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
|
Date: December 18, 2020
|
|
|
|
|
|
|
By:
|
/s/ Frank Sedlarcik
|
|
|
|
Frank Sedlarcik
|
|
|
|
Vice President, Assistant General Counsel and Secretary
|
International Business M... (NYSE:IBM)
Graphique Historique de l'Action
De Mar 2024 à Avr 2024
International Business M... (NYSE:IBM)
Graphique Historique de l'Action
De Avr 2023 à Avr 2024
